Dr. Rahul Bhargava
Hematologist
Senior Consultant
MBBS, MD, DM,Gurgaon, India
Works at Fortis Hospital, Noida | Fortis Memorial Research Institute, Gurgaon
19 years of experience
About Dr. Rahul Bhargava
- Dr. Rahul Bhargava is one of the best Hemato Oncology & Bone Marrow Transplant Surgeons in India.
- He has been practicing for the past 19 years an is trained in treating Castleman Disease.
- He has done close to 1000 bone marrow transplants which are record-breaking in North India.
- Brings along with him an International experience; worked in Vancouver, Canada where he specifically trained in Umbilical cord transplant.
- Member of various prestigious organizations, American Society of Bone Marrow Transplant, American Society of Paediatric Hemato-Oncology, International Society of Paediatric Oncology to name a few.
- He has completed his MBBS & MD from Christian Medical College in Vellore, India. Following which he pursued his DM (Hematology) from the renowned All India Institute of Medical Sciences.
Hospital:
Fortis Memorial Research Institute, Gurgaon
Special Interest
Hematology and Bone Marrow Transplantation
Location:
Gurgaon, India
List Of Treatments
- Metastatic Tumors Treatment
- Chemotherapy
- Radiotherapy
- Adrenal Cancer Treatment
- Anal Cancer Treatment
- Aplastic Anemia
- Bile Duct Cancer Treatment
- Bladder Cancer Treatment
- Bone Cancer Treatment
- Breast Cancer-Surgical
- Cancer in Children
- Carcinoma of Unknown Primary (CUP) Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Endometrial Cancer Treatment
- Esophagus Cancer Treatment
- Ewing Family of Tumors Treatment
- Eye Cancer Treatment
- Gallbladder Cancer Treatment
- Carcinoid Tumors Treatment
- Gastrointestinal Stromal Tumor GIST Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- Hodgkin Disease Treatment
- Kaposi Sarcoma Treatment
- Kidney Cancer Treatment
- Laryngeal and Hypopharyngeal Cancer Treatment
- Acute Lymphocytic Leukemia – ALL in Adults
- Leukemia – Acute Myeloid AML
- Chronic Lymphocytic Leukemia – CLL
- Chronic Myeloid Leukemia- CML
- Chronic Myelomonocytic Leukemia – CMML
- Leukemia in Children
- Liver Cancer
- Lung Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Small-cell Carcinoma Treatment
- Lung Carcinoid Tumor Treatment
- Skin Lymphoma Treatment
- Malignant Mesothelioma Treatment
- Multiple Myeloma Treatment
- Myelodysplastic Syndrome (MDS) Treatment – Preleukemia
- Nasal Cavity and Paranasal Sinus Cancer Treatment
- Nasopharyngeal Cancer Treatment
- Neuroblastoma
- Non-Hodgkin Lymphoma (NHL) Treatment
- Non-Hodgkin Lymphoma In Children
- Oral Cavity and Oropharyngeal Cancer
- Osteosarcoma (OS) Treatment
- Ovarian Cancer Surgery
- Pancreatic Cancer
- Penile Cancer Treatment
- Prostate Cancer-Surgical
- Retinoblastoma (RB) Treatment
- Rhabdomyosarcoma (RMS) Treatment
- Salivary Gland Cancer
- Soft Tissue Sarcoma Treatment
- Skin Cancer
- Basal Cell and Squamous Cell Carcinoma
- Skin Cancer – Melanoma
- Small Intestine Cancer Treatment
- Stomach Cancer Treatment
- Testicular Cancer Treatment
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Uterine Sarcoma
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Waldenstrom Macroglobulinemia
- Wilms Tumor (Nephroblastoma)
- Breast Biopsy
- Allogeneic Bone Marrow Transplant
- Pediatric Bone Marrow Transplant
- Thalassemia Treatment
- Oral Cancer – Surgical
- Bone Marrow Transplant
- Breast Cancer
- Leukemia Treatment
- Hairy Cell Leukemia – HCL
- Fallopian Tube Cancer
- Ovarian Germ Cell Tumor
- Ovarian Primary Peritoneal Cancer
- Medullary Carcinoma
- Papillary Thyroid Cancer Treatment
- Bone Marrow Cancer
- Ovarian Sex Cord Stromal Tumor
- Invasive Lobular Carcinoma
- Colon Cancer Treatment
- Cancer Treatment
- Adenocarcinoma – Glandular Cancer Treatment
- Autologous Bone Marrow Transplant
- Immunotherapy
- Sickle Cell Anemia
- Breast Conservation Surgery – BCS
- Breast Lumpectomy
- IMRT